Skip to main content
. 2022 Apr 7;11(4):727. doi: 10.3390/antiox11040727

Figure 6.

Figure 6

Antioxidant effect and anti-inflammatory effects of PGC. (A) Antioxidant activity of PGC. DCFDA was used to measure the intracellular ROS in N2a cells without any treatment (control) and treated with a different concentration PGC (n = 6, * p < 0.05 compared with control, # p < 0.05 compared with Aβ group, ## p < 0.01 compared with Aβ group). (B) Anti-inflammatory effect of the PGC on Aβ-induced inflammation in BV-2 cells estimated by the expression analysis of inflammation-related genes, TNF-α, IL-6, and IL-1β (n = 6, * p < 0.05 compared with control, ** p < 0.01 compared with control, # p < 0.05 compared with Aβ group, ## p < 0.01 compared with Aβ group).